Canada: 60 Day Bid, 120 Day Pill, 90 Day Decision... The Wisdom Of Solomon Or A Sign Of Things To Come...

In Suncor's hostile bid for Canadian Oil Sands, the target adopted a poison pill that required a 120 day deposit period consistent with the required deposit period in the proposed new take-over bid regime. When Suncor asked the Alberta Securities Commission (ASC) to cease trade the pill, the ASC said it would leave the pill in place for now and cease trade the pill after a total of 90 days. Was this the right decision in the circumstances and is this a sign of further changes to the proposed new take-over bid regime?

In our previous bulletin we considered whether the harmonized take-over bid regime for non-exempt take-over bids proposed by The Canadian Securities Administrators (CSA) would mean the death of poison pills ( see here). The proposed regime is based on three principles:

  • 50% Minimum Tender Condition: this requires that a minimum of more than 50% of all outstanding target securities owned or held by persons other than the bidder and its joint actors be tendered and not withdrawn before the bidder can take up any securities under the bid (i.e. a majority of "independent" security holders must be in favour of the bid);
  • 10 Day Extension Requirement: if the minimum tender condition is met, and all other terms and conditions of the bid have been complied with or waived, the bid must be extended for an additional 10 days (effectively allowing other shareholders to tender once they know that a majority of security holders are in favour of the bid); and
  • 120 Day Deposit Period: the minimum period that a take-over bid must remain open is increased from 35 days to 120 days (subject to the ability of the target company to reduce this period to 35 days).

The proposed regime, and the longer deposit periods in particular, is intended to provide target boards more time to consider and respond to take-over bids.

In the midst of this proposed regime, on October 5, 2015 Suncor Energy Inc. (Suncor) launched a hostile bid for all of the issued and outstanding shares of Canadian Oil Sands Limited (COS). At the time of making the bid, COS had a poison pill in place that provided that the pill would not be triggered if a bid (a "permitted bid") effectively (i) had a 50% Minimum Tender Condition; (ii) included a 10 Day Extension Requirement; and (iii) had a deposit period of 60 days. Suncor structured its bid as a "permitted bid". On October 6, 2015, the Board of COS adopted a new poison pill which provided that in order for a bid to be a "permitted bid" the minimum deposit period must be 120 days.

Under the existing take-over bid regime, the position of the CSA has generally been that there will come a time when a poison pill must go and shareholders must be able to decide to tender or not tender to a bid. After an appropriate length of time, a bidder typically applies to the securities regulators to have the poison pill "cease traded" (effectively rendered ineffective). The appropriate length of time depends on the facts, including whether the Board of the target has had sufficient time to evaluate the bid and potentially surface other bids and the likelihood of other bidders emerging, but the period is generally in the range of 45 to 60 days.

Suncor applied to the ASC to cease trade the new COS poison pill. In its submissions, Suncor argued that (i) under the original COS poison pill the directors had determined that 60 days was sufficient time to evaluate a bid, (ii) from the time that Suncor first approached COS (in March) until the expiry of the bid, almost 10 months would have elapsed; (iii) there are only a limited number of potential bidders who would be interested in COS and if none of them had emerged within the 60 days, they were not likely to emerge; (iv) adopting a new poison pill that changed the rules was an improper defensive tactic; and (v) COS did not have the new poison pill approved by shareholders. Suncor also specifically made the argument that although the proposed take-over bid regime contemplates a 120 deposit period, until the regime is in force the securities commission should not apply those provisions in determining whether to cease trade the new poison pill. At the hearing an executive of Suncor went so far as to state that it would not extend its bid if the ASC affirmed the new poison pill.

In response, COS argued that the original poison pill was adopted at "a very different time, in a very different context, and in very different market conditions" and that it should not preclude COS from adopting a new pill in the face of a hostile bid. COS went on to argue that in the current circumstances the Board and its advisors were of the view that 120 days was required in order to ensure that shareholders were able to make an informed choice. COS argued this additional time was required because (i) additional information with respect to Syncrude's 2016 budget would be available in early December and the lack of this information created an informational advantage to Suncor, (ii) if it took Suncor almost 8 months to determine to make a bid, it is not unreasonable that other potential bidders may also need more than 60 days in order to formulate a potential bid, (iii) 25 parties were reviewing the opportunity to acquire COS and 4 parties had signed confidentiality agreements, (iv) the bid was timed to take advantage of the political and regulatory uncertainty in the Alberta energy industry; and (v) the 120 period under the new poison pill was consistent with the minimum deposit period under the proposed new take-over bid regime.

In its oral decision, the ASC acknowledged that the implementation of the new pill was in the best interests of shareholders and additional time would be useful, and possibly necessary, because potential bidders and COS shareholders would likely want to see the information related to Syncrude's 2016 budget. The ASC also considered Suncor's stated intention not to extend its bid if the 120 day period in the new poison pill was upheld. Ultimately, the ASC concluded that an additional 30 days would be in the best interests of shareholders and determined to cease trade the pill on January 4, 2016. In coming to its decision the ASC did comment that the 60 day period in the original pill may have been sufficient based on the market standards at the time the original pill was adopted, but that did not mean that a 60 day period was sufficient for any bid. Finally, the ASC touched on the proposed new take-over bid regime's requirement for a 120 day bid period and observed that if it comes into force, all bids like Suncor's would be required to have a 120 day bid period.

In the end, the ASC has brought certainty to the length of time that COS' new poison pill will be allowed to stand. The decision, however, does leave two questions. Will the splitting the difference in bid periods be seen as the wisdom of Solomon or the impetus for Suncor to drop its bid, and is settling on a 90 day period for the COS poison pill a signal of any changes to the new take-over bid proposals?

About BLG

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Practice Guides
by Mondaq Advice Centres
Relevancy Powered by MondaqAI
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions